JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Turkheimer, F. E.
Right arrow Articles by Brooks, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Turkheimer, F. E.
Right arrow Articles by Brooks, D. J.
Journal of Nuclear Medicine Vol. 48 No. 1 158-167
© 2007 by Society of Nuclear Medicine


Basic Science Investigation

Reference and Target Region Modeling of [11C]-(R)-PK11195 Brain Studies

Federico E. Turkheimer1–3,, Paul Edison1,3, Nicola Pavese3, Federico Roncaroli4, Alexander N. Anderson1, Alexander Hammers1,5, Alexander Gerhard3,6, Rainer Hinz2, Yan F. Tai1,3 and David J. Brooks1–3,

1 Division of Neuroscience, Department of Clinical Neuroscience, Imperial College London, London, United Kingdom; 2 Hammersmith Imanet, Hammersmith Hospital, London, United Kingdom; 3 PET Neurology Group, MRC CSC, Hammersmith Hospital, London, United Kingdom; 4 Division of Neuroscience, Department of Neuropathology, Imperial College London, London, United Kingdom; 5 PET Epilepsy Group, Hammersmith Hospital, London, United Kingdom; and 6 Department of Psychiatry, University of Mainz, Germany

Correspondence: For correspondence or reprints contact: Federico E. Turkheimer, PhD, Division of Neuroscience and Mental Health, Department of Clinical Neuroscience, DuCane Rd., London W12 0NN, U.K. E-mail: federico.turkheimer{at}imperial.ac.uk

PET with [11C]-(R)-PK11195 is currently the modality of choice for the in vivo imaging of microglial activation in the human brain. In this work we devised a supervised clustering procedure and a new quantification methodology capable of producing binding potential (BP) estimates quantitatively comparable with those derived from plasma input with robust quantitative implementation at the pixel level. Methods: The new methodology uses predefined kinetic classes to extract a gray matter reference tissue without specific tracer binding and devoid of spurious signals (in particular, blood pool and muscle). Kinetic classes were derived from an historical database of 12 healthy control subjects and from 3 patients with Huntington's disease. BP estimates were obtained using rank-shaping exponential spectral analysis (RS-ESA) (both plasma and reference input) and the simplified reference tissue model (SRTM). Comparison between plasma- derived BPs and those produced with the new reference methodology was performed using 6 additional healthy control subjects. Reliability of the new methodology was performed on 4 test–retest studies of patients with Alzheimer's disease. Results: The new algorithm selected reference voxels in gray matter tissue avoiding regions with specific binding located, in particular, in the venous and arterial circulation. Using the new reference, BP values obtained using a plasma input and a reference input were in excellent agreement and highly correlated (r = 0.811, P < 10–5) when calculated with RS-ESA and less so (r = 0.507, P < 0.005) when SRTM was used. In the production of parametric maps, SRTM was used with the new reference extraction, resulting in test–retest variability (10.6%; mean ICC = 0.878) that was superior to that obtained using the previous unsupervised clustering approach (mean ICC = 0.596). Conclusion: Reference region modeling combined with supervised reference tissue extraction produces a robust and reproducible quantitative assessment of [11C]-(R)-PK11195 studies in the human brain.

Key Words: PET • PK11195 • microglia • supervised clustering

COPYRIGHT © 2006 by the Society of Nuclear Medicine, Inc.


Related articles in JNM:

This Month in JNM

JNM 2007 48: 11a-12a. [Full Text]  



This article has been cited by other articles:


Home page
JNMHome page
C. J. Endres, M. G. Pomper, M. James, O. Uzuner, D. A. Hammoud, C. C. Watkins, A. Reynolds, J. Hilton, R. F. Dannals, and M. Kassiou
Initial Evaluation of 11C-DPA-713, a Novel TSPO PET Ligand, in Humans
J. Nucl. Med., August 1, 2009; 50(8): 1276 - 1282.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. Okello, P. Edison, H. A. Archer, F. E. Turkheimer, J. Kennedy, R. Bullock, Z. Walker, A. Kennedy, N. Fox, M. Rossor, et al.
Microglial activation and amyloid deposition in mild cognitive impairment: A PET study
Neurology, January 6, 2009; 72(1): 56 - 62.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
G. Tomasi, P. Edison, A. Bertoldo, F. Roncaroli, P. Singh, A. Gerhard, C. Cobelli, D. J. Brooks, and F. E. Turkheimer
Novel Reference Region Model Reveals Increased Microglial and Reduced Vascular Binding of 11C-(R)-PK11195 in Patients with Alzheimer's Disease
J. Nucl. Med., August 1, 2008; 49(8): 1249 - 1256.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
F. E. Turkheimer, N. Boussion, A. N. Anderson, N. Pavese, P. Piccini, and D. Visvikis
PET Image Denoising Using a Synergistic Multiresolution Analysis of Structural (MRI/CT) and Functional Datasets
J. Nucl. Med., April 1, 2008; 49(4): 657 - 666.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2007 by the Society of Nuclear Medicine.